M2 Macrophage-Derived Extracellular Vehicles-Loaded Hyaluronic Acid-Alginate Hydrogel for Treatment of Osteoarthritis

Abstract

Objective: Osteoarthritis (OA), a high-prevalence degenerative cartilage disease, urgently requires novel therapeutic strategies. M2 macrophage-derived exosomes (M2-Exo) demonstrate therapeutic potential for OA, though their regulatory mechanisms in chondrocyte-macrophage (Mφ) interactions remain to be elucidated. To investigate the regulatory effects of M2-Exo on chondrocytes and Mφ in vitro, and to evaluate the therapeutic effect of the M2-Exo-loaded hydrogel system (ALG-M2Exo) on cartilage damage in a rat OA model.

Methods: In the cell experiment, M2-Exo were extracted and characterized using ultracentrifugation. Different concentrations of M2-Exo were co-cultured with inflammatory chondrocytes or M1Mφ to evaluate their direct anti-inflammatory effects and the ability to promote M1Mφ repolarization to the M2 phenotype, using methods such as EdU, TUNEL, qRT-PCR, and Western blot. Then, the repolarized RM2Mφ were co-cultured with inflammatory chondrocytes to verify their anti-inflammatory efficacy, employing similar detection methods. In the in vivo experiment, sodium iodoacetate was injected to establish a rat knee OA model, followed by interventions including ALG-M2Exo. After 4 and 8 weeks, samples were collected for gross observation and histological staining to assess cartilage damage repair.

Results: In the cell experiment, M2-Exo exhibited typical exosomal characteristics, directly promoting the proliferation of inflammatory chondrocytes, inhibiting their apoptosis, reducing the expression of TNF-α, iNOS, and MMP-13, and increasing the expression of IL-10 and COL II. RM2Mφ showed similar therapeutic effects on inflammatory chondrocytes as M2-Exo. In the in vivo experiment, the ALG-M2Exo group demonstrated superior repair effects on cartilage damage compared to other groups, with the treatment effect at 8 weeks being better than at 4 weeks.

Conclusion: ALG-M2Exo effectively promotes the repair of cartilage damage in OA through both a direct pathway by releasing M2-Exo that act on chondrocytes and an indirect pathway that facilitates the repolarization of M1Mφ to M2Mφ.

Keywords

cartilage regeneration / hydrogel / M2-Exo / macrophage polarization / osteoarthritis

References

[1] S. Huang, Y. Liu, C. Wang, et al., “Strategies for Cartilage Repair in Osteoarthritis Based on Diverse Mesenchymal Stem Cells-Derived Extracellular Vesicles,” Orthopaedic Surgery 15 (2023): 2749-2765.

[2] A. Karoichan, S. Boucenna, and M. Tabrizian, “Therapeutics of the Future: Navigating the Pitfalls of Extracellular Vesicles Research From an Osteoarthritis Perspective,” Journal of Extracellular Vesicles 13 (2024): e12435.

[3] X.-N. Xiang, S.-Y. Zhu, H.-C. He, X. Yu, Y. Xu, and C.-Q. He, “Mesenchymal Stromal Cell-Based Therapy for Cartilage Regeneration in Knee Osteoarthritis,” Stem Cell Research & Therapy 13 (2022): 14.

[4] D. J. Hunter and S. Bierma-Zeinstra, “Osteoarthritis,” Lancet 393 (2019): 1745-1759.

[5] H. Kwon, W. E. Brown, C. A. Lee, et al., “Surgical and Tissue Engineering Strategies for Articular Cartilage and Meniscus Repair,” Nature Reviews Rheumatology 15 (2019): 550-570.

[6] B. C. Menarim, J. N. MacLeod, and L. A. Dahlgren, “Bone Marrow Mononuclear Cells for Joint Therapy: The Role of Macrophages in Inflammation Resolution and Tissue Repair,” World Journal of Stem Cells 13, no. 7 (2021): 825-840, https://doi.org/10.4252/wjsc.v13.i7.825.

[7] Z. Yuan, D. Jiang, M. Yang, et al., “Emerging Roles of Macrophage Polarization in Osteoarthritis: Mechanisms and Therapeutic Strategies,” Orthopaedic Surgery 16 (2024): 532-550.

[8] E. A. Ross, A. Devitt, and J. R. Johnson, “Macrophages: The Good, the Bad, and the Gluttony,” Frontiers in Immunology 12 (2021): 708186.

[9] F. Zhou, J. Mei, S. Yang, et al., “Modified ZIF-8 Nanoparticles Attenuate Osteoarthritis by Reprogramming the Metabolic Pathway of Synovial Macrophages,” ACS Applied Materials & Interfaces 12 (2020): 2009-2022.

[10] S. Li, C. Wu, S. Lin, et al., “HUCMSC-Derived Exosomes Suppress the Titanium Particles-Induced Osteolysis in Mice Through Inhibiting CCL2 and CCL3,” Orthopaedic Surgery 15 (2023): 888-898.

[11] R. Kalluri and V. S. LeBleu, “The Biology, Function, and Biomedical Applications of Exosomes,” Science 367 (2020): eaau6977.

[12] M. O. Gomzikova, V. James, and A. A. Rizvanov, “Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation,” Frontiers in Immunology 10 (2019): 2663.

[13] D. M. Pegtel and S. J. Gould, “Exosomes,” Annual Review of Biochemistry 88 (2019): 487-514.

[14] I. Wortzel, S. Dror, C. M. Kenific, and D. Lyden, “Exosome-Mediated Metastasis: Communication From a Distance,” Developmental Cell 49 (2019): 347-360.

[15] H. Xu and B. Xu, “BMSC-Derived Exosomes Ameliorate Osteoarthritis by Inhibiting Pyroptosis of Cartilage via Delivering miR-326 Targeting HDAC3 and STAT1//NF-κB p65 to Chondrocytes,” Mediators of Inflammation 2021 (2021): 9972805.

[16] Y. Qian, G. Chu, L. Zhang, et al., “M2 Macrophage-Derived Exosomal miR-26b-5p Regulates Macrophage Polarization and Chondrocyte Hypertrophy by Targeting TLR3 and COL10A1 to Alleviate Osteoarthritis,” Journal of Nanobiotechnology 22 (2024): 72.

[17] Z. X. Da-Wa, M. Jun, L. Chao-Zheng, et al., “Exosomes Derived From M2 Macrophages Exert a Therapeutic Effect via Inhibition of the PI3K/AKT/mTOR Pathway in Rats With Knee Osteoarthritic,” BioMed Research International 2021 (2021): 7218067.

[18] W. Guo, L. Su, H. Zhang, and Z. Mi, “Role of M2 Macrophages-Derived Extracellular Vesicles in IL-1β-Stimulated Chondrocyte Proliferation and Inflammatory Responses,” Cell and Tissue Banking 24 (2023): 93-107.

[19] H. Zhang, D. Cai, and X. Bai, “Macrophages Regulate the Progression of Osteoarthritis,” Osteoarthritis and Cartilage 28 (2020): 555-561.

[20] H. Li, Y. Feng, X. Zheng, et al., “M2-Type Exosomes Nanoparticles for Rheumatoid Arthritis Therapy via Macrophage Re-Polarization,” Journal of Controlled Release 341 (2022): 16-30.

[21] L. Lyu, Y. Cai, G. Zhang, et al., “Exosomes Derived From M2 Macrophages Induce Angiogenesis to Promote Wound Healing,” Frontiers in Molecular Biosciences 9 (2022): 1008802.

[22] Y. Zhao, X. Zhao, H. Xu, et al., “Wharton's Jelly MSC-Derived Extracellular Vehicles-Loaded Hyaluronic Acid-Alginate Adhesives for Treatment of Osteoarthritis,” Journal of Materials Science and Technology 142 (2023): 240-252, https://doi.org/10.1016/j.jmst.2022.09.061.

[23] H. Kim, S. Y. Wang, G. Kwak, Y. Yang, I. C. Kwon, and S. H. Kim, “Exosome-Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing,” Advanced Science 6 (2019): 1900513.

[24] S.-M. Moon, S. A. Lee, S. H. Han, et al., “Aqueous Extract of Codium fragile Alleviates Osteoarthritis Through the MAPK/NF-κB Pathways in IL-1β-Induced Rat Primary Chondrocytes and a Rat Osteoarthritis Model,” Biomedicine & Pharmacotherapy 97 (2018): 264-270.

[25] L. He, T. He, J. Xing, et al., “Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Protect Cartilage Damage and Relieve Knee Osteoarthritis Pain in a Rat Model of Osteoarthritis,” Stem Cell Research & Therapy 11 (2020): 276.

[26] J. Xie, Z. Huang, X. Yu, L. Zhou, and F. Pei, “Clinical Implications of Macrophage Dysfunction in the Development of Osteoarthritis of the Knee,” Cytokine & Growth Factor Reviews 46 (2019): 36-44.

[27] J. Lu, H. Zhang, J. Pan, et al., “Fargesin Ameliorates Osteoarthritis via Macrophage Reprogramming by Downregulating MAPK and NF-κB Pathways,” Arthritis Research & Therapy 23 (2021): 142.

[28] T. Ebata, M. A. Terkawi, K. Kitahara, et al., “Noncanonical Pyroptosis Triggered by Macrophage-Derived Extracellular Vesicles in Chondrocytes Leading to Cartilage Catabolism in Osteoarthritis,” Arthritis & Rhematology 75 (2023): 1358-1369.

[29] C.-L. Wu, N. S. Harasymowicz, M. A. Klimak, K. H. Collins, and F. Guilak, “The Role of Macrophages in Osteoarthritis and Cartilage Repair,” Osteoarthritis and Cartilage 28 (2020): 544-554.

[30] M. Dai, B. Sui, Y. Xue, X. Liu, and J. Sun, “Cartilage Repair in Degenerative Osteoarthritis Mediated by Squid Type II Collagen via Immunomodulating Activation of M2 Macrophages, Inhibiting Apoptosis and Hypertrophy of Chondrocytes,” Biomaterials 180 (2018): 91-103.

[31] K. Li, G. Yan, H. Huang, et al., “Anti-Inflammatory and Immunomodulatory Effects of the Extracellular Vesicles Derived From Human Umbilical Cord Mesenchymal Stem Cells on Osteoarthritis via M2 Macrophages,” Journal of Nanobiotechnology 20 (2022): 38.

[32] M. Kang, C.-C. Huang, Y. Lu, et al., “Bone Regeneration Is Mediated by Macrophage Extracellular Vesicles,” Bone 141 (2020): 115627.

[33] H. Kim, S. Y. Wang, G. Kwak, Y. Yang, I. C. Kwon, and S. H. Kim, “Exosome-Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing,” Advanced Science 6 (2019): 1900513.

[34] L. Bouchareychas, P. Duong, S. Covarrubias, et al., “Macrophage Exosomes Resolve Atherosclerosis by Regulating Hematopoiesis and Inflammation via MicroRNA Cargo,” Cell Reports 32 (2020): 107881.

[35] B. Liu, Y. Xian, X. Chen, et al., “Inflammatory Fibroblast-Like Synoviocyte-Derived Exosomes Aggravate Osteoarthritis via Enhancing Macrophage Glycolysis,” Advanced Science 11 (2024): e2307338.

[36] F. Zhou, J. Mei, S. Yang, et al., “Modified ZIF-8 Nanoparticles Attenuate Osteoarthritis by Reprogramming the Metabolic Pathway of Synovial Macrophages,” ACS Applied Materials & Interfaces 12 (2020): 2009-2022.

[37] H. Kim, S. Y. Wang, G. Kwak, Y. Yang, I. C. Kwon, and S. H. Kim, “Exosome-Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing,” Advanced Science 6 (2019): 1900513.

[38] E. A. Ross, A. Devitt, and J. R. Johnson, “Macrophages: The Good, the Bad, and the Gluttony,” Frontiers in Immunology 12 (2021): 708186.

[39] F.-X. Zhang, P. Liu, W. Ding, et al., “Injectable Mussel-Inspired Highly Adhesive Hydrogel With Exosomes for Endogenous Cell Recruitment and Cartilage Defect Regeneration,” Biomaterials 278 (2021): 121169.

[40] P. K. Sacitharan, “Ageing and Osteoarthritis,” Sub-Cellular Biochemistry 91 (2019): 123-159.

[41] R. F. Loeser, J. A. Collins, and B. O. Diekman, “Ageing and the Pathogenesis of Osteoarthritis,” Nature Reviews Rheumatology 12 (2016): 412-420.

[42] M. H. Li, R. Xiao, J. B. Li, and Q. Zhu, “Regenerative Approaches for Cartilage Repair in the Treatment of Osteoarthritis,” Osteoarthritis and Cartilage 25 (2017): 1577-1587.

[43] H. Zhang, C. Lin, C. Zeng, et al., “Synovial Macrophage M1 Polarisation Exacerbates Experimental Osteoarthritis Partially Through R-Spondin-2,” Annals of the Rheumatic Diseases 77 (2018): 1524-1534.

[44] H. Li, D. Wang, Y. Yuan, and J. Min, “New Insights on the MMP-13 Regulatory Network in the Pathogenesis of Early Osteoarthritis,” Arthritis Research & Therapy 19 (2017): 248.

[45] H. Hoshi, R. Akagi, S. Yamaguchi, et al., “Effect of Inhibiting MMP13 and ADAMTS5 by Intra-Articular Injection of Small Interfering RNA in a Surgically Induced Osteoarthritis Model of Mice,” Cell and Tissue Research 368 (2017): 379-387.

[46] G. Ruan, J. Xu, K. Wang, et al., “Associations Between Knee Structural Measures, Circulating Inflammatory Factors and MMP13 in Patients With Knee Osteoarthritis,” Osteoarthritis and Cartilage 26 (2018): 1063-1069.

[47] T. Wang and C. He, “Pro-Inflammatory Cytokines: The Link Between Obesity and Osteoarthritis,” Cytokine & Growth Factor Reviews 44 (2018): 38-50.

[48] H. Cao, W. Li, H. Zhang, et al., “Bio-Nanoparticles Loaded With Synovial-Derived Exosomes Ameliorate Osteoarthritis Progression by Modifying the Oxidative Microenvironment,” Journal of Nanobiotechnology 22 (2024): 271.

[49] Y. W. Choo, M. Kang, H. Y. Kim, et al., “M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors,” ACS Nano 12 (2018): 8977-8993.

[50] L. Pang, H. Jin, Z. Lu, et al., “Treatment With Mesenchymal Stem Cell-Derived Nanovesicle-Containing Gelatin Methacryloyl Hydrogels Alleviates Osteoarthritis by Modulating Chondrogenesis and Macrophage Polarization,” Advanced Healthcare Materials 12 (2023): 2300315.

[51] G. Kwak, J. Cheng, H. Kim, et al., “Sustained Exosome-Guided Macrophage Polarization Using Hydrolytically Degradable PEG Hydrogels for Cutaneous Wound Healing: Identification of Key Proteins and MiRNAs, and Sustained Release Formulation,” Small 18 (2022): 2200060.

[52] I. Malyshev and Y. Malyshev, “Current Concept and Update of the Macrophage Plasticity Concept: Intracellular Mechanisms of Reprogramming and M3 Macrophage ‘Switch’ Phenotype,” BioMed Research International 2015 (2015): 341308.

[53] Y. Deng, J. Lu, W. Li, et al., “Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation,” Nature Communications 9 (2018): 4564.

[54] S. Piao, W. Du, Y. Wei, Y. Yang, X. Feng, and L. Bai, “Protectin DX Attenuates IL-1β-Induced Inflammation via the AMPK/NF-κB Pathway in Chondrocytes and Ameliorates Osteoarthritis Progression in a Rat Model,” International Immunopharmacology 78 (2020): 106043.

[55] X. Wu, Y. Wang, Y. Xiao, R. Crawford, X. Mao, and I. Prasadam, “Extracellular Vesicles: Potential Role in Osteoarthritis Regenerative Medicine,” Journal of Orthopaedic Translation 21 (2020): 73-80.

[56] X. Pang, S.-S. Wang, M. Zhang, et al., “OSCC Cell-Secreted Exosomal CMTM6 Induced M2-Like Macrophages Polarization via ERK1/2 Signaling Pathway,” Cancer Immunology, Immunotherapy 70 (2021): 1015-1029.

RIGHTS & PERMISSIONS

2025 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.